Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Mono Pharmacare Ltd

Pharmaceuticals & Biotechnology | Small Cap

Mono Pharmacare Ltd Health Insights
Health Score : 6.16Health Score : 6.16

Mono Pharmacare Ltd demonstrates a mixed financial performance. The company shows remarkable growth in revenue, operating profit, EPS, assets and net income. Profitability is generally strong, supported by good gross profit margins, ROCE, ROE, operating margin and net margin. The company's solvency position appears reasonable, indicating a balanced approach to debt and equity. However, liquidity is a concern, as reflected in lower cash and operating cash flow ratios. Efficiency metrics are weak, particularly in inventory and receivables management. The company's coverage ratios are also somewhat low, suggesting a limited ability to cover interest and dividend payments. Overall, Mono Pharmacare exhibits strong growth and profitability but needs to address its liquidity and efficiency challenges to ensure sustainable financial health.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Mono Pharmacare Ltd Health Insights
Health Score : 6.16Health Score : 6.16

Mono Pharmacare Ltd demonstrates a mixed financial performance. The company shows remarkable growth in revenue, operating profit, EPS, assets and net income. Profitability is generally strong, supported by good gross profit margins, ROCE, ROE, operating margin and net margin. The company's solvency position appears reasonable, indicating a balanced approach to debt and equity. However, liquidity is a concern, as reflected in lower cash and operating cash flow ratios. Efficiency metrics are weak, particularly in inventory and receivables management. The company's coverage ratios are also somewhat low, suggesting a limited ability to cover interest and dividend payments. Overall, Mono Pharmacare exhibits strong growth and profitability but needs to address its liquidity and efficiency challenges to ensure sustainable financial health.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

N/A

Highly Undervalued

Industry Median

28.93

Highly Undervalued
Highly Undervalued

Small Cap Median

26.92

Highly Undervalued

P/E RATIO

6.26

P/B RATIO

0.62

Highly Undervalued

Industry Median

3.18

Highly Undervalued
Highly Undervalued

Small Cap Median

2.63

Highly Undervalued

P/S RATIO

0.12

Highly Undervalued

Industry Median

3.41

Highly Undervalued
Highly Undervalued

Small Cap Median

2.40

Highly Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Undervalued

EV/EBITDA RATIO

5.60

Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹10.95 as on Jun 18, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company exhibits strong growth across multiple dimensions. This robust growth suggests that the company is successfully expanding its market presence and capitalizing on opportunities. The company is well-positioned for continued success and value creation.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2024Mar 2025
Revenue Growth Rate351.8537.7
Operating Profit Growth Rate20033.33
Earnings Per Share (EPS) Growth142.1126.81
Asset Growth Rate28.5735.8
Net Income Growth Rate10050
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 4.00

The company's financial performance is characterized by modest earnings per share, limited book value per share, and a focus on capital expenditures. The company is investing heavily in its operations. This strategic focus on reinvestment could drive future growth and profitability.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2024Mar 2025
Adjusted Earnings Per Share (Adjusted EPS)1.111.67
Cash Earnings Per Share (Cash EPS)1.111.67
Book Value Per Share15.5617.78
Dividend Per Share (DPS)00
Capital Expenditures (CapEx)0.20.2
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 9.60

The company exhibits strong profitability. The company is capable of generating profits from its sales. Investors are more likely to be attracted to the company due to its strong financial performance.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
AverageReturn on Assets (ROA)Average
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2024Mar 2025
Gross Profit Margin4.924.76
Return on Capital Employed (ROCE)6.977.15
Return on Equity (ROE)7.219.44
Return on Assets (ROA)7.417.27
Operating Margin4.924.76
Net Margin1.641.79
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 3.67

The company demonstrates a high level of efficiency in utilizing its fixed assets to generate revenue. However, there are significant challenges in managing inventory and receivables. The company faces difficulties in efficiently converting sales into cash. These inefficiencies can tie up working capital and negatively impact profitability.

ExcellentFixed Asset Turnover RatioExcellent
PoorInventory Turnover RatioPoor
WeakReceivables Turnover RatioWeak
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2024Mar 2025
Fixed Asset Turnover Ratio122168
Inventory Turnover Ratio3.093.32
Receivables Turnover Ratio4.524.54
Days Sales in Inventory Ratio118.12109.94
Receivable Days80.7580.4
Capital Turnover Ratio1.421.5
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 4.40

The company's ability to meet its interest expenses is reasonable, but its dividend coverage is non-existent. It can comfortably handle its debt obligations, but it does not currently distribute dividends to shareholders. The company's financial flexibility is limited by its dividend policy.

AverageInterest Coverage RatioAverage
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2023Mar 2024Mar 2025
Interest Coverage Ratio222
Equity Dividend Coverage RatioN/AN/AN/A
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 7.90

The company's solvency position demonstrates a balanced approach to financial leverage. It indicates a healthy mix of debt and equity financing. The company's ability to meet its long-term obligations. The business has a solid foundation with low debt compared to its assets.

GoodDebt RatioGood
GoodDebt to Equity RatioGood
AverageEquity RatioAverage
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2024Mar 2025
Debt Ratio0.380.45
Debt to Equity Ratio0.610.82
Equity Ratio0.620.55
Debt To Asset Ratio0.210.24
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 4.36

The company's liquidity position reveals a mixed picture. While they can cover their short term liabilities with their short term assets, its ability to quickly convert assets into cash is somewhat limited. The company struggles to generate positive operating cash flow, posing challenges for day-to-day operations. The absence of cash reserves further constrains its financial flexibility.

AverageCurrent RatioAverage
AverageQuick RatioAverage
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2024Mar 2025
Current Ratio2.22.07
Quick Ratio1.051.03
Cash Ratio00.02
Operating Cash Flow Ratio-0.25-0.08
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 7 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Medicamen Organics Ltd6.30-6.83Neutral-3.75-2.50-4.02
2Mono Pharmacare Ltd6.166.26Neutral8.001.753.00
3JFL Life Sciences Ltd6.079.54Neutral12.001.946.00
4Walpar Nutritions Ltd5.299.26Neutral6.662.093.00
5Mangalam Drugs and Organics Ltd4.50-1.07Neutral-15.00-27.68-44.00
6Lasa Supergenerics Ltd4.39-2.61Highly Undervalued-7.00-6.80-34.00
7Sunrest Lifescience Ltd4.177.06Highly Undervalued10.213.608.00
Management Assessment Summary
OrangeBalanced Management

The management of Mono Pharmacare demonstrates potential alongside notable challenges. Revenue growth is robust, but profitability is strained by declining margins. Capital efficiency metrics such as ROCE and ROE are moderate. Increasing debt levels pose a concern, while stable shareholding patterns suggest continued promoter confidence. The focus should be on improving profitability and managing debt to enhance overall management effectiveness.

Category Metric Value Assessment
PROS Sales Growth 37.60% Strong revenue expansion.
Promoter Holding 56.72% Suggests confidence and alignment.
CONS OPM Decline 5% Indicates operational efficiency challenges.
Increasing Debt ₹54 Cr. Suggests rising leverage.
AverageFinancial Performance & GrowthAverage
AverageCapital Efficiency & ReturnsAverage
WeakFinancial Health & PrudenceWeak
WeakStrategic & Operational IndicatorsWeak
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Strategic & Operational Indicators

Risk Assessment Summary
OrangeBalanced Risk

Mono Pharmacare faces moderate risk. Sales growth is strong, but profitability is a concern due to declining margins. Increasing debt levels elevate financial risk, and inefficient working capital management ties up cash. Stable promoter holding provides some reassurance. The company's ability to sustain growth and profitability while managing its financial obligations will determine its risk profile.

AverageOff-balance sheet exposure quantificationAverage
AverageContingent liability evaluationAverage
AverageForeign exchange or interest rate exposureAverage
AverageRegulatory compliance cost trendsAverage
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

03.

Foreign exchange or interest rate exposure

04.

Regulatory compliance cost trends

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1010.96Bearish
  3. SMA 2011.15Bearish
  4. SMA 5011.43Bearish
  5. EMA 1010.99Bearish
  6. EMA 2011.12Bearish
  7. EMA 5011.40Bearish
  8. DEMA 1010.87Bullish
  9. DEMA 2010.91Bullish
  10. DEMA 5011.02Bearish
  11. TEMA 1010.87Bullish
  12. TEMA 2010.87Bullish
  13. TEMA 5010.91Bullish
  14. MACD-0.16Bearish
  15. ADX15.21Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI39.96Neutral
  3. CCI-74.57Neutral
  4. ROC 90.46Bullish
  5. ROC 14-4.37Bearish
  6. ROC 25-4.78Bearish
  7. Stoch K7.84Oversold
  8. Stoch D3.92Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper11.63Neutral
  3. BB Middle11.15Neutral
  4. BB Lower10.68Neutral
  5. ATR0.13Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI27.46Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1011.11Bearish
  3. SMA 2011.28Bearish
  4. SMA 5011.60Bearish
  5. EMA 1011.07Bearish
  6. EMA 2011.22Bearish
  7. EMA 5011.55Bearish
  8. DEMA 1010.91Bullish
  9. DEMA 2010.96Bearish
  10. DEMA 5011.14Bearish
  11. TEMA 1010.88Bullish
  12. TEMA 2010.92Bullish
  13. TEMA 50N/AN/A
  14. MACD-0.20Bearish
  15. ADX12.62Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI41.23Neutral
  3. CCI-93.79Neutral
  4. ROC 9-4.37Bearish
  5. ROC 14-4.78Bearish
  6. ROC 25-7.20Bearish
  7. Stoch K7.02Oversold
  8. Stoch D6.60Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper11.86Neutral
  3. BB Middle11.28Neutral
  4. BB Lower10.70Neutral
  5. ATR0.21Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI42.80Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1011.21Bearish
  3. SMA 2011.44Bearish
  4. SMA 5012.13Bearish
  5. EMA 1011.18Bearish
  6. EMA 2011.41Bearish
  7. EMA 5011.73Bearish
  8. DEMA 1010.95Bearish
  9. DEMA 2011.03Bearish
  10. DEMA 50N/AN/A
  11. TEMA 1010.93Bullish
  12. TEMA 2010.92Bullish
  13. TEMA 50N/AN/A
  14. MACD-0.29Bearish
  15. ADX12.63Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI43.23Neutral
  3. CCI-111.86Oversold
  4. ROC 9-2.67Bearish
  5. ROC 14-7.20Bearish
  6. ROC 25-4.78Bearish
  7. Stoch K12.77Oversold
  8. Stoch D15.72Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper12.31Neutral
  3. BB Middle11.44Neutral
  4. BB Lower10.58Neutral
  5. ATR0.41Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI50.84Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1011.36Bearish
  3. SMA 2011.64Bearish
  4. SMA 5011.94Bearish
  5. SMA 10013.43Bearish
  6. SMA 20018.66Bearish
  7. EMA 1011.38Bearish
  8. EMA 2011.62Bearish
  9. EMA 5012.21Bearish
  10. EMA 10014.08Bearish
  11. EMA 20018.60Bearish
  12. DEMA 1011.10Bearish
  13. DEMA 2011.27Bearish
  14. DEMA 5010.87Bullish
  15. DEMA 1009.84Bullish
  16. DEMA 2009.39Bullish
  17. TEMA 1011.06Bearish
  18. TEMA 2011.10Bearish
  19. TEMA 5011.61Bearish
  20. TEMA 10010.37Bullish
  21. TEMA 200N/AN/A
  22. MACD-0.29Bearish
  23. ADX20.72Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI42.02Neutral
  3. CCI-99.58Neutral
  4. ROC 14-10.61Bearish
  5. ROC 25-15.12Bearish
  6. Stoch K15.10Oversold
  7. Stoch D18.51Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper12.54Neutral
  3. BB Middle11.64Neutral
  4. BB Lower10.74Neutral
  5. ATR0.56High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI52.92Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2012.00Bearish
  3. SMA 5017.30Bearish
  4. EMA 2012.92Bearish
  5. EMA 5017.02Bearish
  6. DEMA 2010.88Bullish
  7. DEMA 509.65Bullish
  8. TEMA 2011.69Bearish
  9. TEMA 50N/AN/A
  10. MACD-1.38Bullish
  11. ADX25.61Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI38.26Neutral
  3. CCI-75.73Neutral
  4. ROC 142.19Bullish
  5. ROC 25-29.39Bearish
  6. Stoch K32.26Neutral
  7. Stoch D35.67Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper13.71Neutral
  3. BB Middle12.01Neutral
  4. BB Lower10.30Neutral
  5. ATR1.22Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI53.48Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 612.49Bearish
  3. SMA 1217.59Bearish
  4. SMA 2424.87Bearish
  5. EMA 613.81Bearish
  6. EMA 1217.40Bearish
  7. EMA 2425.37Bearish
  8. DEMA 611.19Bullish
  9. DEMA 1210.37Bullish
  10. DEMA 24N/AN/A
  11. TEMA 611.79Bullish
  12. TEMA 12N/AN/A
  13. TEMA 24N/AN/A
  14. MACDN/AN/A
  15. ADX12.11Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI42.10Neutral
  3. CCIN/AN/A
  4. ROC 25-72.02Bearish
  5. ROC 50N/AN/A
  6. Stoch KN/AN/A
  7. Stoch DN/AN/A
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper37.63Neutral
  3. BB Middle22.20Neutral
  4. BB Lower6.77Neutral
  5. ATR6.35Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI19.92Oversold